Human Investigation Committee

Beaumont Health System Human Investigation Committee
3811 West Thirteen Mile Road
Royal Oak, MI 48073
Interdepartmental mail code: 104 RBS

Phone: 248-551-0662
Fax: 248-551-2884
Hours of Operation: 8 a.m. - 5 p.m.
Map to Research Institute

Federal Wide Assurance

The Beaumont Human Investigation Committee operates under a Federal Wide Assurance with the Department of Health and Human Services to protect human research participants.

The identification number of the Beaumont HIC FWA is FWA 00002516.

Please refer to the FWA for current expiration date.

Institutional Authority

The HIC is the final approving authority of research involving human subjects at Beaumont hospitals and Beaumont facilities. This includes biomedical research or clinical investigation that involves a test article and one or more human subjects, including testing of drugs for human use, medical devices for human use, biological products for human use, electronic products, and food and color additives.

Systematic investigations, including research development, testing and evaluation involving human subjects or identifiable information for the purpose of increasing generalized knowledge, will be considered research and require review by the HIC.

The HIC has the authority to approve, require modifications in, or disapprove all research activities involving human subjects.

The purpose of the HIC review is to assure, both in the Initial and Continuing Review, that appropriate steps are taken to protect the rights and welfare of human research subjects.

Meetings of the Committee

The HIC meets twice a month, on the 1st and 3rd Friday, to review and make determinations regarding new project submissions, Annual or Continuing Review of projects, Protocol Amendments, Serious Adverse Event Reports, Protocol Deviation Reports and Data Safety Monitoring Board Reports.